Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OH/Akron
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Akron, OH

Studies commonly pay $75 to $4,500 per completed study

394 clinical trials are currently recruiting participants within 30 miles of Akron. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

394studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Akron right now

Top 25 of 394 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (11.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Systemic Lupus Erythematosus Phase 3 Interventional 550 participants sought
Paramount Med Rsrch and Consult LLC — Middleburg Heights, Ohio (24.6 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06133972)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Aultman Hospital — Canton, Ohio (20.8 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
UH Minoff Health Center at Chagrin Highlands — Orange, Ohio (25.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

Type 2 Diabetes Phase 2 Interventional 60 participants sought
Diabetes and Endocrinology Associates of Stark County — Canton, Ohio (20.8 mi) · Sponsor: Biomea Fusion Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07502495)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Tri-County Hematology & Oncology Associates, Inc. ( Site 0076) — Massillon, Ohio (19.6 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Polymyositis, Dermatomyositis Phase 3 Interventional 240 participants sought
Research Site — Middleburg Heights, Ohio (24.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06455449)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

Intracerebral Hemorrhage, Stroke N/A Observational 1,018 participants sought
Cleveland Clinic Akron General — Akron, Ohio (0.2 mi) · Sponsor: Zeenat Qureshi Stroke Institute
See eligibility & contact on ClinicalTrials.gov (NCT06402968)

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES) Phase 3 Interventional 14 participants sought
Research Site — Highland Hills, Ohio (25.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06512883)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 714 participants sought
Gabrail Cancer Center Research — Canton, Ohio (20.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06758401)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (11.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania Phase 3 Interventional 450 participants sought
Neuro-Behavioral Clinical Research — North Canton, Ohio (15.4 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06929273)

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a) Phase 3 Interventional 5,700 participants sought
Akron Hospital Summa Health System — Akron, Ohio (0.2 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07517263)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05675410)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 3 Interventional 486 participants sought
UHHS-Chagrin Highlands Medical Center — Beachwood, Ohio (26.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07097142)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Cleveland Clinic Akron General — Akron, Ohio (0.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Aultman Hospital — Canton, Ohio (20.8 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

Lipidemia, Type 2 Diabetes (T2DM) Phase 3 Interventional 300 participants sought
Summit Research Group — Munroe Falls, Ohio (6.2 mi) · Sponsor: NewAmsterdam Pharma
See eligibility & contact on ClinicalTrials.gov (NCT07219602)
Actively enrolling

Studies you may be able to join near Akron

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Akron

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Synexus - Akron

★ 4.2
530 S Main St #1712, Akron, OH 44311
(330) 252-1500
"They (SyNexus) conduct a few clinical trials at the facility."
— Kenneth M Craddock II, 5★

Akron Gastro Research

★ 5.0
789 White Pond Dr Ste C, Akron, OH 44320
(330) 269-7348
"No waiting, bu,t there is always a smiling face waiting to greet you."
— Bev Boltz, 5★

Cummings Center for the History of Psychology

★ 4.7
73 S College St, Akron, OH 44325
(330) 972-7285
"This was truly a memorable experience. It is interactive and highly informative. Be prepared to spend several hours you won't regret it. Also don't f…"
— Tony Loret de Mola, 5★

Clinical Research Management

★ 5.0
1265 Ridge Rd Ste a, Hinckley, OH 44233
(330) 278-2343
"I am not sure what this place is but when I have time, I’d like to drive by and get some photos to add to this review with some details."
— Joseph Powell, 5★

Clinical Research Trials

4875 Higbee Ave NW, Canton, OH 44718
(330) 754-4322

Akron Children's Genetic Center, Akron

★ 2.8
215 W Bowery St Level 5, Akron, OH 44308
(330) 543-8792
"I’m currently not happy with the decisions of this department and the push back we have received trying to advocate for our son. Absolutely ridiculou…"
— s p, 1★

Akron Children's Cystic Fibrosis Center

215 W Bowery St Level 6, Akron, OH 44308
(330) 543-3249

Pinnacle Fertility Ohio - Akron

★ 4.0 (194 reviews)
95 Arch St #250, Akron, OH 44304
(330) 375-7722
"After 5 long years of infertility, countless appointments, procedures, tears, and prayers, we are finally expecting our miracle baby, and we owe so m…"
— M'kayla, 5★

Clinical Research Solutions - Cleveland, OH

★ 5.0
6900 Pearl Rd #305, Middleburg Heights, OH 44130
(440) 340-9010
"Outstanding staff. I look forward to seeing Cara and Brandon. Great experience!"
— steve allen, 5★

Clinical trials in Akron: what's recruiting

The Akron area currently has 394 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Akron, the most active research areas are:

  • Cancer & Oncology13 studies
  • Heart & Vascular4 studies
  • Immune & Skin2 studies
  • Diabetes & Metabolism2 studies
  • Brain & Mental Health2 studies

Every listing shows the study phase, the recruiting site and its distance from Akron, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Akron

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Akron participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Akron safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Akron, OH?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Akron?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Akron.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Akron typically complete one or two studies per year.

Paid clinical trials near Akron

Other metros within reach

Canton, OH307 Cleveland, OH1,409 Lorain, OH1,304 Youngstown, OH87 Pittsburgh, PA1,237 Erie, PA88 Columbus, OH1,340 Detroit, MI1,190

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Akron Bladder Issues Due To Spinal Cord Injury in Akron All conditions

More of OH

Cleveland1,409 Columbus1,340 Lorain1,304 Cincinnati1,131 Dayton310 Canton307 Toledo208 Youngstown87

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts